International pharma specialists meet at Bosch
Caption: Pharmatag 2016: international symposium in Crailsheim, Germany On the second day, several lectures about unusual projects, current challenges and future trends as well as a podium discussion addressing quality, flexibility and industry 4.0 in pharmaceutical manufacturing complemented the program.
Representatives of AbbVie, Eli Lilly, NNE Pharmaplan, Roche Diagnostics and Vetter Pharma reported on unusual projects, current challenges and future trends, such as filling of highly potent pharmaceuticals and innovative approaches for the development of parenteral dosage forms.
Connected industry and its opportunities for pharmaceutical production — 300 international pharma experts discussed this topic from 10 to 11 May in Crailsheim, Germany. “Pharmatag”, hosted by the division Packaging Technology, took place for the eighth time. With 50% more guests from the pharmaceutical, biopharmaceutical and process technology industries, the symposium achieved record attendance. “Pharmatag 2016 offered the 300 participants from all over the world a versatile mix of lectures, podium discussion and new technologies,” said Joachim Brenner, general manager at Bosch Packaging Technology in Crailsheim. “The growing number of participants of this triannual event shows that Bosch Packaging Technology plays a leading role in the pharmaceutical industry and the high customer demand for events like this.”
Focus on pharmaceutical line competence
On day one, the guests of Pharmatag had the opportunity to look behind the scenes of the Crailsheim production facility and to receive first-hand information about Bosch's pharmaceutical line competence as well as current portfolio expansions. A special highlight was the launch of the new ALF 5000 filling and closing machine for ampoules and injection bottles. Apart from an output of 600 containers per minute, the machine features high flexibility and process safety.
The second day with lectures and a podium discussion was opened by Friedbert Klefenz, President of Bosch Packaging Technology. In his key note speech, Prof. Thomas Bauernhansl, head of the Fraunhofer Institute for Manufacturing Engineering and Automation, and the Institute of Industrial Manufacturing and Management at the University of Stuttgart, gave insights into the opportunities of industry 4.0, as well as an outlook on the future of pharmaceutical production.
Representatives of AbbVie, Eli Lilly, NNE Pharmaplan, Roche Diagnostics and Vetter Pharma reported on unusual projects, current challenges and future trends, such as filling of highly potent pharmaceuticals and innovative approaches for the development of parenteral dosage forms. The subsequent podium discussion addressed quality, flexibility and industry 4.0 in pharmaceutical manufacturing. Claudia Petersen, Global Director Business Development at Gerresheimer, led through the program.
CPI software for connected serialization
Apart from numerous filling machines and lines for liquid pharmaceuticals, the participants also received information about exterior washing of vials and ampoules (RAN 3080), the combination of visual inspection technology and leak detection (AIM 3000), matching downstream equipment (RIL 3010), as well as special customer projects. Secondary packaging and serialization solutions completed the presentation of Bosch's pharmaceutical line competence.
Moreover, Bosch showcased further industry 4.0 application possibilities for the pharmaceutical industry. Combined with the CPI software from Bosch, Track & Trace solutions can be integrated into the company IT in a multi-level process. This way, manufacturers are not only able to process the entire order management; they also control both import and export of the serial numbers. All relevant data is available in the company network and can be transferred to regulatory or company-owned databases according to regulatory requirements.
A further important part of Bosch's line competence consists in after-sales services, which support customers in flexibly adapting their existing equipment to future market requirements.
General manager Joachim Brenner was satisfied with the outcome of Pharmatag 2016: “Not long ago, we hosted the Meet & Match event of BIOPRO Baden-Württemberg, and for the last two days we welcomed representatives of the leading international pharmaceutical companies. This shows the importance of the Bosch Packaging Technology site in Crailsheim for the industry — regionally and internationally.”
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.